CFO4Life Group’s Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF PDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Buy
6,732
+60
+0.9% +$2.76K 0.04% 180
2026
Q1
$289K Buy
6,672
+43
+0.6% +$1.92K 0.04% 168
2025
Q4
$280K Buy
6,629
+77
+1% +$3.19K 0.04% 183
2025
Q3
$269K Buy
6,552
+42
+0.6% +$1.69K 0.04% 184
2025
Q2
$253K Buy
6,510
+59
+0.9% +$2.11K 0.04% 186
2025
Q1
$216K Buy
6,451
+51
+0.8% +$1.69K 0.04% 195
2024
Q4
$202K Buy
6,400
+65
+1% +$2.15K 0.04% 199
2024
Q3
$223K Buy
6,335
+45
+0.7% +$1.51K 0.04% 187
2024
Q2
$203K Buy
6,290
+53
+0.8% +$1.74K 0.04% 187
2024
Q1
$205K Buy
+6,237
New +$199K 0.04% 178

Other funds holding PDN

CFO4Life Group's PDN Position: Q2 2026 in Review

CFO4Life Group increased its Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF (PDN) stake by 0.9% in Q2 2026, buying an estimated $2.76K and bringing the position to 6,732 shares worth $303K. The position accounts for 0.04% of the portfolio, ranked #180.

CFO4Life Group first reported a position in PDN in Q1 2024 and has held it in 10 quarters since. 100 funds tracked by Wall St. Rank hold PDN as of Q2 2026.

  • CFO4Life Group held 6,732 shares of Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF worth $303K as of Q2 2026.
  • CFO4Life Group bought 60 Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF shares in Q2 2026, an estimated $2.76K.
  • Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF made up 0.04% of CFO4Life Group's portfolio in Q2 2026, its #180 holding.
  • CFO4Life Group first reported a position in Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF in Q1 2024 and has held it in 10 quarters since.
  • 100 funds tracked by Wall St. Rank held Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF as of Q2 2026.

Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.